T1	Treatment 2 33	single nasal allergen challenge
T2	Treatment 569 587	placebo-controlled
T3	Treatment 690 721	single nasal allergen challenge
T4	Treatment 1001 1164	Sputum cells and supernatant levels of ECP, sICAM, IL-5 and IL-10, and plasma levels of IL-5 and ECP, were measured before and 24 h after nasal allergen challenge.
T5	Treatment 1165 1269	After a washout period of at least 4 weeks, the procedure was repeated with placebo challenge (diluent).
T6	Treatment 2027 2058	single nasal allergen challenge
